US Stock MarketDetailed Quotes

BTAI BioXcel Therapeutics

Watchlist

1.185
+0.015+1.28%

Trading Jul 22 14:52 ET

44.47MMarket Cap-228P/E (TTM)

BioXcel Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

66.18%-17.71M

-14.53%-155.01M

30.48%-26.86M

-20.52%-37.58M

-15.42%-38.21M

-61.52%-52.35M

-64.74%-135.34M

-93.85%-38.64M

-54.39%-31.19M

-47.90%-33.1M

Net income from continuing operations

49.26%-26.79M

-8.02%-179.05M

59.39%-22.26M

-20.76%-50.49M

-42.06%-53.52M

-67.76%-52.8M

-55.01%-165.76M

-109.79%-54.81M

-55.93%-41.81M

-36.39%-37.67M

Operating gains losses

-112.99%-30K

-206.08%-436K

-125.74%-122K

--1K

---546K

--231K

793.48%411K

--474K

----

Depreciation and amortization

-2.50%78K

-2.75%318K

-3.70%78K

-7.06%79K

-3.57%81K

3.90%80K

10.10%327K

6.58%81K

10.39%85K

6.33%84K

Other non cash items

66.54%1.33M

82.30%3.53M

25.58%1.25M

27.26%789K

--691K

--801K

--1.94M

--997K

--620K

----

Change In working capital

176.99%4.27M

-80.60%2.02M

-193.49%-9.41M

45.91%8.02M

2,899.69%8.96M

-14.52%-5.55M

108.90%10.4M

159.47%10.07M

242.64%5.5M

80.14%-320K

-Change in receivables

-777.14%-307K

171.37%177K

367.74%664K

---304K

---148K

---35K

---248K

--0

-Change in inventory

-1,457.58%-448K

99.70%-6K

104.68%27K

-615.38%-93K

103.79%27K

104.84%33K

---1.99M

---577K

---13K

---713K

-Change in prepaid assets

144.92%901K

173.96%2.89M

13.12%1.16M

5.29%2.25M

141.17%1.48M

42.36%-2.01M

-3,891.26%-3.91M

-44.14%1.03M

416.74%2.14M

-103.28%-3.59M

-Change in payables and accrued expense

221.55%4.21M

-104.29%-722K

-208.18%-10.97M

82.88%6.17M

88.87%7.54M

-411.98%-3.46M

247.09%16.83M

396.48%10.14M

50.18%3.38M

2,458.33%3.99M

-Change in other current assets

----

4.35%72K

----

-65.33%69K

--67K

-Change in other current liabilities

-7.79%-83K

-8.87%-319K

-9.33%-82K

-9.46%-81K

-8.22%-79K

-8.45%-77K

-23.63%-293K

-8.70%-75K

55.95%-74K

---73K

Cash from discontinued investing activities

Operating cash flow

66.18%-17.71M

-14.53%-155.01M

30.48%-26.86M

-20.52%-37.58M

-15.42%-38.21M

-61.52%-52.35M

-64.74%-135.34M

-93.85%-38.64M

-54.39%-31.19M

-47.90%-33.1M

Investing cash flow

Cash flow from continuing investing activities

85.61%-20K

68.76%-139K

81.00%-19K

Net PPE purchase and sale

----

85.61%-20K

--0

----

68.76%-139K

--0

81.00%-19K

Cash from discontinued investing activities

Investing cash flow

--0

85.61%-20K

--0

-5.26%-20K

--0

68.76%-139K

--0

81.00%-19K

Financing cash flow

Cash flow from continuing financing activities

10.26%26.63M

-72.44%26.52M

4,146.00%2.12M

-99.62%250K

24.15M

-6.06%96.24M

50K

42,221.13%30.05M

-34.85%66.14M

Net issuance payments of debt

----

--0

----

--98.6M

--0

--30M

----

Net common stock issuance

8.46%26.74M

--27.03M

--2.38M

--0

--24.66M

--0

Proceeds from stock option exercised by employees

--0

79.51%508K

--0

35.14%250K

--258K

-80.54%283K

--50K

-54.29%48K

-62.78%185K

Net other financing activities

84.73%-117K

61.53%-1.02M

---252K

--0

---766K

---2.65M

--0

----

Cash from discontinued financing activities

Financing cash flow

10.26%26.63M

-72.44%26.52M

4,146.00%2.12M

--0

-99.62%250K

--24.15M

-6.06%96.24M

--50K

42,221.13%30.05M

-34.85%66.14M

Net cash flow

Beginning cash position

-66.33%65.22M

-16.84%193.73M

-61.28%89.96M

-45.37%127.55M

-17.42%165.52M

-16.84%193.73M

9.31%232.97M

-8.14%232.31M

-14.50%233.45M

3.31%200.44M

Current changes in cash

131.63%8.92M

-227.46%-128.5M

35.89%-24.74M

-3,202.64%-37.58M

-215.02%-37.98M

13.31%-28.2M

-297.71%-39.24M

-93.49%-38.59M

94.35%-1.14M

-58.23%33.02M

End cash Position

-55.21%74.14M

-66.33%65.22M

-61.28%89.96M

-45.37%127.55M

-17.42%165.52M

-16.84%193.73M

-8.14%232.31M

-14.50%233.45M

Free cash flow

66.18%-17.71M

-14.43%-155.03M

30.48%-26.86M

-20.52%-37.58M

-15.41%-38.23M

-60.92%-52.35M

-64.02%-135.48M

-93.74%-38.64M

-54.26%-31.19M

-47.33%-33.12M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	66.18%-17.71M	-14.53%-155.01M	30.48%-26.86M	-20.52%-37.58M	-15.42%-38.21M	-61.52%-52.35M	-64.74%-135.34M	-93.85%-38.64M	-54.39%-31.19M	-47.90%-33.1M
Net income from continuing operations	49.26%-26.79M	-8.02%-179.05M	59.39%-22.26M	-20.76%-50.49M	-42.06%-53.52M	-67.76%-52.8M	-55.01%-165.76M	-109.79%-54.81M	-55.93%-41.81M	-36.39%-37.67M
Operating gains losses	-112.99%-30K	-206.08%-436K	-125.74%-122K	--1K	---546K	--231K	793.48%411K	--474K	----	----
Depreciation and amortization	-2.50%78K	-2.75%318K	-3.70%78K	-7.06%79K	-3.57%81K	3.90%80K	10.10%327K	6.58%81K	10.39%85K	6.33%84K
Other non cash items	66.54%1.33M	82.30%3.53M	25.58%1.25M	27.26%789K	--691K	--801K	--1.94M	--997K	--620K	----
Change In working capital	176.99%4.27M	-80.60%2.02M	-193.49%-9.41M	45.91%8.02M	2,899.69%8.96M	-14.52%-5.55M	108.90%10.4M	159.47%10.07M	242.64%5.5M	80.14%-320K
-Change in receivables	-777.14%-307K	171.37%177K	367.74%664K	---304K	---148K	---35K	---248K	---248K	--0	--0
-Change in inventory	-1,457.58%-448K	99.70%-6K	104.68%27K	-615.38%-93K	103.79%27K	104.84%33K	---1.99M	---577K	---13K	---713K
-Change in prepaid assets	144.92%901K	173.96%2.89M	13.12%1.16M	5.29%2.25M	141.17%1.48M	42.36%-2.01M	-3,891.26%-3.91M	-44.14%1.03M	416.74%2.14M	-103.28%-3.59M
-Change in payables and accrued expense	221.55%4.21M	-104.29%-722K	-208.18%-10.97M	82.88%6.17M	88.87%7.54M	-411.98%-3.46M	247.09%16.83M	396.48%10.14M	50.18%3.38M	2,458.33%3.99M
-Change in other current assets	----	----	----	4.35%72K	----	----	----	----	-65.33%69K	--67K
-Change in other current liabilities	-7.79%-83K	-8.87%-319K	-9.33%-82K	-9.46%-81K	-8.22%-79K	-8.45%-77K	-23.63%-293K	-8.70%-75K	55.95%-74K	---73K
Cash from discontinued investing activities
Operating cash flow	66.18%-17.71M	-14.53%-155.01M	30.48%-26.86M	-20.52%-37.58M	-15.42%-38.21M	-61.52%-52.35M	-64.74%-135.34M	-93.85%-38.64M	-54.39%-31.19M	-47.90%-33.1M
Investing cash flow
Cash flow from continuing investing activities		85.61%-20K	0	0			68.76%-139K	0	0	81.00%-19K
Net PPE purchase and sale	----	85.61%-20K	--0	--0	----	----	68.76%-139K	--0	--0	81.00%-19K
Cash from discontinued investing activities
Investing cash flow	--0	85.61%-20K	--0	--0	-5.26%-20K	--0	68.76%-139K	--0	--0	81.00%-19K
Financing cash flow
Cash flow from continuing financing activities	10.26%26.63M	-72.44%26.52M	4,146.00%2.12M	0	-99.62%250K	24.15M	-6.06%96.24M	50K	42,221.13%30.05M	-34.85%66.14M
Net issuance payments of debt	----	--0	--0	--0	----	----	--98.6M	--0	--30M	----
Net common stock issuance	8.46%26.74M	--27.03M	--2.38M	--0	--0	--24.66M	--0	--0	--0	--0
Proceeds from stock option exercised by employees	--0	79.51%508K	--0	--0	35.14%250K	--258K	-80.54%283K	--50K	-54.29%48K	-62.78%185K
Net other financing activities	84.73%-117K	61.53%-1.02M	---252K	--0	--0	---766K	---2.65M	--0	--0	----
Cash from discontinued financing activities
Financing cash flow	10.26%26.63M	-72.44%26.52M	4,146.00%2.12M	--0	-99.62%250K	--24.15M	-6.06%96.24M	--50K	42,221.13%30.05M	-34.85%66.14M
Net cash flow
Beginning cash position	-66.33%65.22M	-16.84%193.73M	-61.28%89.96M	-45.37%127.55M	-17.42%165.52M	-16.84%193.73M	9.31%232.97M	-8.14%232.31M	-14.50%233.45M	3.31%200.44M
Current changes in cash	131.63%8.92M	-227.46%-128.5M	35.89%-24.74M	-3,202.64%-37.58M	-215.02%-37.98M	13.31%-28.2M	-297.71%-39.24M	-93.49%-38.59M	94.35%-1.14M	-58.23%33.02M
End cash Position	-55.21%74.14M	-66.33%65.22M	-66.33%65.22M	-61.28%89.96M	-45.37%127.55M	-17.42%165.52M	-16.84%193.73M	-16.84%193.73M	-8.14%232.31M	-14.50%233.45M
Free cash flow	66.18%-17.71M	-14.43%-155.03M	30.48%-26.86M	-20.52%-37.58M	-15.41%-38.23M	-60.92%-52.35M	-64.02%-135.48M	-93.74%-38.64M	-54.26%-31.19M	-47.33%-33.12M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall